ATOS icon

Atossa Therapeutics
ATOS

Overview Fund Activity

93 hedge funds and large institutions have $102M invested in Atossa Therapeutics in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 15 closing their positions.

Holders
93
Holders Change
+4
Holders Change %
+4.49%
% of All Funds
1.63%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
20
Increased
29
Reduced
26
Closed
15
Calls
$35M
Puts
$15.6M
Net Calls
+$19.5M
Net Calls Change
+$7.32M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$23M
2
Citadel Advisors
2
Citadel Advisors
Florida
$3.33M
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$2.92M
4
BlackRock
4
BlackRock
New York
$31.1M
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$5.71M

Top Sellers

1
Group One Trading
1
Group One Trading
Illinois
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$805K
3
SM
3
Sabby Management
Florida
$0
4
Invesco
4
Invesco
Georgia
$121K
5
Millennium Management
5
Millennium Management
New York
$861K
Name Holding Trade Value Shares
Change 		Shares
Change %
Wells Fargo
101
Wells Fargo
California
– -$7K -1,164 Closed
Federated Hermes
102
Federated Hermes
Pennsylvania
– -$1K -138 Closed
CAM
103
CenterStar Asset Management
Illinois
– -$10K – –
1 2 3 4
5